The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.
about
Tumor location and patient age predict biological signatures of high-grade gliomas.Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.Clinical and immunological correlates of long term survival in glioblastoma.Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma
P2860
The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@en
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@nl
type
label
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@en
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@nl
prefLabel
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@en
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@nl
P2093
P2860
P1433
P1476
The impact of MGMT methylation ...... reated with chemoradiotherapy.
@en
P2093
Aditya Shenoy
Andrew R Brodbelt
Atik Baborie
Brian Haylock
Christopher P Millward
Daniel Crooks
David Husband
Helen Wong
Michael D Jenkinson
Rasheed Zakaria
P2860
P2888
P304
P356
10.1007/S00701-016-2928-8
P577
2016-08-15T00:00:00Z